Shanghai Serum Bio-Technology (SH:688163) Ge Long Hui·2025-08-20 08:43Group 1 - The core viewpoint of the article is that Sairun Biotech (688163.SH) has not included its products in the national drug procurement led by the National Healthcare Security Administration [1] - The company currently has no plans to adjust the price of its anti-snake venom serum [1] - The anti-snake venom serum plays a crucial role in quickly neutralizing toxins, reducing harm to patients, shortening recovery time, improving prognosis, and decreasing treatment costs for complications caused by poisoning [1] Group 2 - The article highlights that with ongoing social progress and an increase in public health awareness and demand, the construction of a snakebite treatment system is expected to improve [1] - The key role and usage principles of anti-snake venom serum are anticipated to receive more attention and implementation in clinical settings [1]